Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+138.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+138.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
13.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$75.60M+244.5%
2024$21.94M+41.3%
2023$15.53M+178.8%
2022$5.57M+20.3%
2021$4.63M-